Satoshi Yamanaka

7PUBLICATIONS
19CO-AUTHORS
Biologically active moleculesGenetically modified animalsMolecular medicineProteins and peptidesNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 30, 2025
In-cell proximity target validation methods for heterobifunctional molecules with CRBN- or VHL-binder using AirID.

Kohdai Yamada, Satoshi Yamanaka, Hiroyuki Yamakoshi

|Nov 29, 2024
Cell-type specific, inducible and acute degradation of targeted protein in mice by two degron systems.

Motoi Yamashita, Chihiro Ogawa, Baihao Zhang

|Aug 18, 2023
Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation.

Satoshi Yamanaka, Hirotake Furihata, Yuta Yanagihara

|Jan 11, 2022
A proximity biotinylation-based approach to identify protein-E3 ligase interactions induced by PROTACs and molecular glues.

Satoshi Yamanaka, Yuto Horiuchi, Saya Matsuoka

|Jan 20, 2021
Thalidomide and its metabolite 5-hydroxythalidomide induce teratogenicity via the cereblon neosubstrate PLZF.

Satoshi Yamanaka, Hidetaka Murai, Daisuke Saito

|Sep 19, 2020
An IMiD-induced SALL4 degron system for selective degradation of target proteins.

Satoshi Yamanaka, Yuki Shoya, Saya Matsuoka

Pageof 2